| Primary |
| Hepatitis B |
34.3% |
| Drug Use For Unknown Indication |
28.7% |
| Product Used For Unknown Indication |
8.4% |
| Hiv Infection |
4.2% |
| Headache |
2.8% |
| Hepatic Cirrhosis |
2.8% |
| Hepatitis B E Antigen Negative |
2.8% |
| Hepatitis |
2.1% |
| Non-hodgkin's Lymphoma |
2.1% |
| Blood Pressure Increased |
1.4% |
| Chronic Hepatitis |
1.4% |
| Chronic Hepatitis B |
1.4% |
| Hiv Test |
1.4% |
| Placental Disorder |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Ascites |
0.7% |
| Depression |
0.7% |
| Epilepsy |
0.7% |
| Gastritis Prophylaxis |
0.7% |
| Hepatitis B Virus |
0.7% |
|
| Polymerase Chain Reaction |
7.0% |
| Renal Failure |
7.0% |
| Viral Hepatitis Carrier |
7.0% |
| Weight Decreased |
7.0% |
| Drug Exposure During Pregnancy |
5.3% |
| Hepatic Enzyme Increased |
5.3% |
| Infertility Male |
5.3% |
| Leukopenia |
5.3% |
| Pancytopenia |
5.3% |
| Polyneuropathy |
5.3% |
| Pyrexia |
5.3% |
| Splenomegaly |
5.3% |
| Vomiting |
5.3% |
| Abortion Spontaneous |
3.5% |
| Hepatitis B Virus |
3.5% |
| Hypokalaemia |
3.5% |
| Neuropathy Peripheral |
3.5% |
| Nuclear Magnetic Resonance Imaging Abnormal |
3.5% |
| Pregnancy Of Partner |
3.5% |
| Prothrombin Level Decreased |
3.5% |
|
| Secondary |
| Hepatitis B |
38.8% |
| Hepatic Cirrhosis |
24.5% |
| Drug Use For Unknown Indication |
18.1% |
| Hepatitis B Virus Test |
3.7% |
| Chronic Hepatitis B |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Diffuse Large B-cell Lymphoma |
2.1% |
| Antiretroviral Therapy |
1.6% |
| Hiv Infection |
1.6% |
| Hepatitis Fulminant |
1.1% |
| Diabetes Mellitus |
0.5% |
| Epilepsy |
0.5% |
| Hypertension |
0.5% |
| Medical Diet |
0.5% |
|
| Hepatic Neoplasm Malignant |
18.0% |
| Oesophageal Varices Haemorrhage |
8.0% |
| Renal Failure |
8.0% |
| Aspartate Aminotransferase Increased |
6.0% |
| Liver Disorder |
6.0% |
| Weight Decreased |
6.0% |
| Ascites |
4.0% |
| Colitis Ulcerative |
4.0% |
| Diabetes Mellitus |
4.0% |
| Hepatic Failure |
4.0% |
| Hepatitis |
4.0% |
| Hypoglycaemia |
4.0% |
| Pneumonia |
4.0% |
| Renal Tubular Disorder |
4.0% |
| Splenomegaly |
4.0% |
| White Blood Cell Count Decreased |
4.0% |
| Death |
2.0% |
| Drug Ineffective |
2.0% |
| Hepatic Enzyme Increased |
2.0% |
| Hepatic Function Abnormal |
2.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.1% |
| Hepatitis B |
10.5% |
| Product Used For Unknown Indication |
9.0% |
| Diffuse Large B-cell Lymphoma |
8.9% |
| Non-hodgkin's Lymphoma |
6.0% |
| Liver Transplant |
5.5% |
| Prophylaxis |
4.2% |
| Hypertension |
3.8% |
| Hepatic Neoplasm Malignant |
3.4% |
| Diabetes Mellitus |
2.6% |
| Aplastic Anaemia |
1.7% |
| Angioimmunoblastic T-cell Lymphoma |
1.6% |
| Peripheral T-cell Lymphoma Unspecified |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Renal Transplant |
1.5% |
| Infection Prophylaxis |
1.4% |
| Chronic Graft Versus Host Disease |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| B-cell Lymphoma |
1.0% |
| Constipation |
1.0% |
|
| Renal Impairment |
9.6% |
| Peripheral Sensory Neuropathy |
8.9% |
| Pyrexia |
7.5% |
| Renal Failure |
7.5% |
| Respiratory Failure |
6.8% |
| Pleural Effusion |
5.5% |
| Rash |
5.5% |
| White Blood Cell Count Decreased |
4.8% |
| Liver Transplant Rejection |
4.1% |
| Osteoporosis |
4.1% |
| Systemic Inflammatory Response Syndrome |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Urinary Tract Infection |
4.1% |
| Wrist Fracture |
4.1% |
| Abortion Spontaneous |
3.4% |
| Febrile Neutropenia |
3.4% |
| Platelet Count Decreased |
3.4% |
| Viral Load Increased |
3.4% |
| Ascites |
2.7% |
| Hepatic Failure |
2.7% |
|
| Interacting |
| Glomerulonephritis Membranous |
25.0% |
| Hepatitis B |
25.0% |
| Nephritic Syndrome |
25.0% |
| Portal Hypertension |
25.0% |
|
| Obstructive Airways Disorder |
100.0% |
|
